This metabolite incorporates a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 close to 50% from the guardian drug. Plasma concentrations of this metabolite are close to 40% of Those people viewed for sildenafil, so that the metabolite accounts for about 20% of sild